文献速递系统性红斑狼疮

晚发型与早发型系统性红斑狼疮肺部表现比较:系统评价与荟萃分析

Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.
PubMed 文献 · Semin Arthritis Rheum · 2018-01-31

该系统评价与荟萃分析纳入39项研究,比较晚发型与早发型系统性红斑狼疮(SLE)患者的肺部表现;晚发型组间质性肺病(OR=2.56(1.27,5.16))、胸膜炎(OR=1.53(1.19,1.96))和浆膜炎(OR=1.31(1.05,1.65))的 odds 均更高。

要点

  • 晚发型SLE患者发生间质性肺病的 odds 约为早发型患者的2.56倍(OR=2.56(1.27,5.16))。
  • 晚发型SLE患者胸膜炎(OR=1.53(1.19,1.96))和浆膜炎(OR=1.31(1.05,1.65))的 odds 也更高。
  • 研究质量平均Newcastle-Ottawa量表评分为6.3±0.7(满分9分),属中等水平。

核心结论

  • 晚发型SLE患者相比年轻患者,肺部表现更常见,尤其是间质性肺病和浆膜炎。
  • 免疫系统年龄相关变化、烟草暴露、种族及可能与干燥综合征重叠应在未来研究中考察。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、CINAHL、Web of Science、Cochrane Library和EMBASE数据库。
  • 纳入标准要求包含美国风湿病学会SLE分类标准、早发型SLE对照组,且晚发型SLE定义不得为<50岁。
  • 共纳入39项研究,代表10,963例早发型和1,656例晚发型SLE患者。
  • 使用Newcastle-Ottawa质量量表评价研究质量,采用森林图比较按年龄分组的肺部表现 odds ratio(95%置信区间),用I²评估研究异质性。

主要发现

  • 晚发型组发生间质性肺病的 odds 约为早发型组的2.56倍(OR=2.56(1.27,5.16))。
  • 晚发型组胸膜炎的 odds 更高(OR=1.53(1.19,1.96))。
  • 晚发型组浆膜炎的 odds 更高(OR=1.31(1.05,1.65))。
  • 研究质量平均Newcastle-Ottawa量表评分为6.3±0.7(量表范围0-9),属中等水平。

关键数值与推荐

  • 间质性肺病:晚发型 vs 早发型 OR=2.56(1.27,5.16)。
  • 胸膜炎:晚发型 vs 早发型 OR=1.53(1.19,1.96)。
  • 浆膜炎:晚发型 vs 早发型 OR=1.31(1.05,1.65)。
  • 研究质量平均Newcastle-Ottawa量表评分6.3±0.7(量表范围0-9)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Phenotypes differ between late- and early-onset systemic lupus erythematosus (SLE). Prior studies suggested that there may be more pulmonary disease among late-onset patients. Our objective was to perform a systematic review and meta-analysis to evaluate the differences in pulmonary manifestations in late- versus early-onset SLE. METHODS: We searched the literature using PubMed, CINAHL, Web of Science, Cochrane Library, and EMBASE. We excluded studies that did not include American College of Rheumatology SLE classification criteria, an early-onset SLE comparison group, or those that defined late-onset SLE as <50 years of age. We rated study quality using the Newcastle-Ottawa Quality Scale. We used Forest plots to compare odds ratios (95% confidence intervals) of pulmonary manifestations by age. Study heterogeneity was assessed using I2. RESULTS: Thirty-nine studies, representing 10,963 early-onset and 1656 late-onset patients with SLE, met eligibility criteria. The odds of developing several pulmonary manifestations were higher in the late-onset group. Interstitial lung disease (ILD) was nearly three times more common (OR = 2.56 (1.27, 5.16)). Pleuritis (OR = 1.53 (1.19, 1.96)) and serositis (OR = 1.31 (1.05, 1.65)) were also more common in the late-onset group. The mean Newcastle-Ottawa Quality Scale score for study quality was moderate (6.3 ± 0.7, scale 0-9). CONCLUSIONS: Pulmonary manifestations of SLE were more common in late-onset SLE patients compared to their younger peers, in particular ILD and serositis. Age-related changes of the immune system, tobacco exposure, race, and possible overlap with Sjögren's syndrome should be examined in future studies.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Medlin JL, Hansen KE, McCoy SS, et al. Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018. PMID: 29550111. doi:10.1016/j.semarthrit.2018.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。